Showing results (11-20 of 78) with videos related to
Sort By:
Pageof 8
Antimicrobial Agents and Chemotherapy|April 2, 2008
Reduced Candida glabrata susceptibility secondary to an FKS1 mutation developed during candidemia treatmentJohn D Cleary, Guillermo Garcia-Effron, Stanley W Chapman, et al.Medical Mycology|September 22, 2021
The natural occurring Y129F polymorphism in Rhizopus oryzae (R. arrhizus) Cyp51Ap accounts for its intrinsic voriconazole resistanceDaiana Macedo, Florencia Leonardelli, Matias S Cabeza, et al.Antimicrobial Agents and Chemotherapy|August 29, 2007
A Ser678Pro substitution in Fks1p confers resistance to echinocandin drugs in Aspergillus fumigatusEleusa Maria F Rocha, Guillermo Garcia-Effron, Steven Park, et al.Antimicrobial Agents and Chemotherapy|September 17, 2008
Caspofungin-resistant Candida tropicalis strains causing breakthrough fungemia in patients at high risk for hematologic malignanciesGuillermo Garcia-Effron, Dimitrios P Kontoyiannis, Russell E Lewis, et al.Antimicrobial Agents and Chemotherapy|June 24, 2009
Effect of Candida glabrata FKS1 and FKS2 mutations on echinocandin sensitivity and kinetics of 1,3-beta-D-glucan synthase: implication for the existing susceptibility breakpointGuillermo Garcia-Effron, Samuel Lee, Steven Park, et al.Revista Iberoamericana De Micologia|January 27, 2021
SARS-CoV-2 and Aspergillus section Fumigati coinfection in an immunocompetent patient treated with corticosteroidsNatalia Sasoni, Milton Rodriguez Müller, Graciela Posse, et al.Journal of Clinical Microbiology|July 29, 2011
Assessment of two new molecular methods for identification of Candida parapsilosis sensu lato speciesGuillermo Garcia-Effron, Emilia Canton, Javier Pemán, et al.Antimicrobial Agents and Chemotherapy|April 30, 2008
A naturally occurring proline-to-alanine amino acid change in Fks1p in Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis accounts for reduced echinocandin susceptibilityGuillermo Garcia-Effron, Santosh K Katiyar, Steven Park, et al.International Journal of Antimicrobial Agents|June 2, 2026
Wild-type MIC distributions and Epidemiological Cut-off Values for Ibrexafungerp, Manogepix, and Rezafungin against WHO Fungal Priority PathogensMaria J Morelo, Carolina Firacative, Guillermo Garcia-Effron, et al.Antimicrobial Agents and Chemotherapy|April 11, 2007
Serum differentially alters the antifungal properties of echinocandin drugsPadmaja Paderu, Guillermo Garcia-Effron, Sergey Balashov, et al.Pageof 8